Suppr超能文献

四触角 N-连接聚糖水平升高而非核心岩藻糖基化与肝癌组织相关。

Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.

机构信息

Department of Microbiology and Immunology, Drexel University College of Medicine, Doylestown, PA, USA.

出版信息

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):925-33. doi: 10.1158/1055-9965.EPI-11-1183. Epub 2012 Apr 6.

Abstract

BACKGROUND

Alterations in glycosylation have long been associated with the development of cancer. In the case of primary hepatocellular carcinoma (HCC), one alteration that has often been associated is increased amounts of fucose attached to the N-glycans of serum proteins secreted by the liver.

METHODS

In an effort to determine the origin of this increased fucosylation, we have conducted N-linked glycan analysis of HCC tissue, the surrounding nontumor tissue, and compared this to tissue from a nondiseased adult liver.

RESULTS

Surprisingly, no difference in the level of fucosylation was observed from the three donor groups, suggesting that the increased levels of fucosylation observed in serum of those with HCC is not the result of increased synthesis of fucosylated proteins in the cancer tissue. On the other hand, increased levels of a tetra-antennary glycan were observed in the HCC tissue as compared with the surrounding tissue or to the nondiseased livers.

CONCLUSIONS

This represents, to our knowledge, one of the first reports associating increased levels of branching with the development of HCC.

IMPACT

The identification of increased levels of tetra-antennary glycan on liver tumor tissue, as opposed to adjacent or nondiseased tissue may lead to improved detection of HCC.

摘要

背景

糖基化的改变长期以来一直与癌症的发展有关。在原发性肝细胞癌(HCC)的情况下,经常与之一致的改变是肝脏分泌的血清蛋白的 N-糖链上附着的更多的岩藻糖。

方法

为了确定这种增加的岩藻糖基化的起源,我们对 HCC 组织、周围非肿瘤组织进行了 N-连接糖链分析,并将其与非病变成人肝脏的组织进行了比较。

结果

令人惊讶的是,三个供体组之间的岩藻糖基化水平没有差异,这表明 HCC 患者血清中观察到的增加的岩藻糖基化水平不是癌症组织中岩藻糖基化蛋白合成增加的结果。另一方面,与周围组织或非病变肝脏相比,HCC 组织中观察到四天线聚糖的水平增加。

结论

据我们所知,这是首次将增加的分支程度与 HCC 的发展联系起来的报告之一。

影响

与相邻或非病变组织相比,在肝肿瘤组织上识别出增加的四天线聚糖水平可能会导致 HCC 的检测得到改善。

相似文献

1
Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissue.
Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):925-33. doi: 10.1158/1055-9965.EPI-11-1183. Epub 2012 Apr 6.
2
N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging.
J Proteome Res. 2018 Oct 5;17(10):3454-3462. doi: 10.1021/acs.jproteome.8b00323. Epub 2018 Sep 5.
3
Input of serum haptoglobin fucosylation profile in the diagnosis of hepatocellular carcinoma in patients with non-cirrhotic liver disease.
Clin Res Hepatol Gastroenterol. 2020 Oct;44(5):681-691. doi: 10.1016/j.clinre.2019.12.010. Epub 2020 Jan 18.
4
Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
J Proteome Res. 2014 Jun 6;13(6):2986-97. doi: 10.1021/pr500128t. Epub 2014 May 7.
6
ESI-LC-MS Method for Haptoglobin Fucosylation Analysis in Hepatocellular Carcinoma and Liver Cirrhosis.
J Proteome Res. 2015 Dec 4;14(12):5388-95. doi: 10.1021/acs.jproteome.5b00792. Epub 2015 Nov 3.
10
Highly enhanced fucosylation of serum glycoproteins in patients with hepatocellular carcinoma.
J Gastroenterol Hepatol. 1999 May;14(5):436-45. doi: 10.1046/j.1440-1746.1999.01882.x.

引用本文的文献

1
Spatial omics-based machine learning algorithms for the early detection of hepatocellular carcinoma.
Commun Med (Lond). 2024 Dec 3;4(1):258. doi: 10.1038/s43856-024-00677-7.
3
Data Independent Acquisition Mass Spectrometry Enhanced Personalized Glycosylation Profiling of Haptoglobin in Hepatocellular Carcinoma.
J Proteome Res. 2024 Aug 2;23(8):3571-3584. doi: 10.1021/acs.jproteome.4c00227. Epub 2024 Jul 12.
4
Spatial Omics Reveals that Cancer-Associated Glycan Changes Occur Early in Liver Disease Development in a Western Diet Mouse Model of MASLD.
J Proteome Res. 2024 Feb 2;23(2):786-796. doi: 10.1021/acs.jproteome.3c00672. Epub 2024 Jan 11.
5
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma.
Front Oncol. 2023 Oct 18;13:1213898. doi: 10.3389/fonc.2023.1213898. eCollection 2023.
6
Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications.
Oncogene. 2023 Jun;42(24):1970-1979. doi: 10.1038/s41388-023-02702-w. Epub 2023 May 16.
7
Aberrant N-glycosylation in cancer: MGAT5 and β1,6-GlcNAc branched N-glycans as critical regulators of tumor development and progression.
Cell Oncol (Dordr). 2023 Jun;46(3):481-501. doi: 10.1007/s13402-023-00770-4. Epub 2023 Jan 23.
9
Modeling and integration of N-glycan biomarkers in a comprehensive biomarker data model.
Glycobiology. 2022 Sep 19;32(10):855-870. doi: 10.1093/glycob/cwac046.
10
Increased expression of core-fucosylated glycans in human lung squamous cell carcinoma.
RSC Adv. 2019 Jul 16;9(38):22064-22073. doi: 10.1039/c9ra04341a. eCollection 2019 Jul 11.

本文引用的文献

1
Specific posttranslational modification regulates early events in mammary carcinoma formation.
Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21116-21. doi: 10.1073/pnas.1013405107. Epub 2010 Nov 15.
3
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
J Proteome Res. 2010 Oct 1;9(10):4888-96. doi: 10.1021/pr100414r.
5
Detection of hepatocellular carcinoma using glycomic analysis.
Clin Cancer Res. 2009 Mar 1;15(5):1808-13. doi: 10.1158/1078-0432.CCR-07-5261. Epub 2009 Feb 17.
7
Biological function of fucosylation in cancer biology.
J Biochem. 2008 Jun;143(6):725-9. doi: 10.1093/jb/mvn011. Epub 2008 Jan 24.
9
Complex N-glycan and metabolic control in tumor cells.
Cancer Res. 2007 Oct 15;67(20):9771-80. doi: 10.1158/0008-5472.CAN-06-4580.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验